| Literature DB >> 29073743 |
Sang Won Jeon1, Changsu Han2, Joonho Choi3, Young-Hoon Ko2,4, Ho-Kyoung Yoon2, Yong-Ku Kim2.
Abstract
OBJECTIVE: The purpose of this study was to investigate the therapeutic effects of eye movement desensitization and reprocessing (EMDR) on post-traumatic growth (PTG).Entities:
Keywords: Eye movement desensitization reprocessing; Post-traumatic growth; Post-traumatic stress disorders; Resilience; Trauma.
Year: 2017 PMID: 29073743 PMCID: PMC5678482 DOI: 10.9758/cpn.2017.15.4.320
Source DB: PubMed Journal: Clin Psychopharmacol Neurosci ISSN: 1738-1088 Impact factor: 2.582
Subject demographics, information about inpatient treatment, and DSM-5 diagnoses at the beginning of EMDR
| Patient | Sex | Age (yr) | Admission (hospitalized day) | Diagnosis at the beginning of EMDR |
|---|---|---|---|---|
| Patient 1 | M | 42 | No | Partial PTSD |
| Patient 2 | M | 18 | 14 | Partial PTSD |
| Patient 3 | F | 18 | 14 | Partial PTSD |
| Patient 4 | F | 18 | 14 | Partial PTSD |
| Patient 5 | M | 58 | 21 | Partial PTSD |
| Patient 6 | F | 18 | 14 | PTSD |
| Patient 7 | M | 18 | 14 | Partial PTSD |
| Patient 8 | F | 38 | No | PTSD, MDD |
| Mean (SD) | 28.5 (15.6) | 15.2 (2.9) |
DSM-5, the Diagnostic and Statistical Manual of Mental Disorders 5th edition; EMDR, eye movement desensitization and reprocessing; M, male; F, female; PTSD, post-traumatic stress disorder; MDD, major depressive disorder; SD, standard deviation.
Changes in mean scores of eight patients for each scale
| Variable | CD-RISC | CAPS | PTGI | SRGS |
|---|---|---|---|---|
| Pre-session | 50.0 (15.8) | 49.1 (11.1) | 46.8 (8.2) | 44.5 (6.4) |
| After session 4 | - | 41.0 (18.0) | 54.9 (11.8) | 54.9 (10.7) |
| After session 8 | 57.6 (18.3) | 37.6 (17.7) | 62.1 (13.4) | 62.3 (14.1) |
| Three months after treatment completion | 55.1 (18.7) | 37.9 (20.6) | 62.1 (16.8) | 61.4 (16.4) |
| Statistics from pre- to post-treatment | Z(8)=−2.386 | Z(8)=−2.176 | Z(8)=−2.380 | Z(8)=−2.380 |
| Increase and decrease rates (%) | +10.2 | −22.8 | +32.7 | +38.0 |
| Effect size | 0.30 | 0.71 | 1.22 | 1.48 |
Values are presented as mean (standard deviation).
CD-RISC, Connor-Davidson Resilience Scale; CAPS, Clinician-Administered PTSD Scale; PTGI, Post-Traumatic Growth Inventory; SRGS, Stress-Related Growth Scale.
Statistic: Wilcoxon signed rank test from pre- to post-treatment;
p<0.05,
p<0.025.
Fig. 1Changes in mean scores for each scale from pre-treatment to three months after treatment completion (n=8).
CD-RISC, Connor-Davidson Resilience Scale; CAPS, Clinician-Administered PTSD Scale; PTGI, Post-Traumatic Growth Inventory; SRGS, Stress-Related Growth Scale; Tx, treatment.
Fig. 2Changes in scores of each patient for each scale from pre-treatment to three months after treatment completion.
CD-RISC, Connor-Davidson Resilience Scale; CAPS, Clinician-Administered PTSD Scale; PTGI, Post-Traumatic Growth Inventory; SRGS, Stress-Related Growth Scale; Tx, treatment.